Our poly-JIA patients required both MTX and anti-TNF treatment while none receiving only MTX; whereas in their study, the group receiving just MTX were predominantly oligo-JIA subjects (71%). The gene discussed is TNF; the disease is juvenile idiopathic arthritis.